Sorrento Therapeutics (SRNE)
OTHER OTC:SRNE
Holding SRNE?
Track your performance easily

Sorrento Therapeutics (SRNE) Cash flow

5,282 Followers

Sorrento Therapeutics Cash Flow

SRNE's free cash flow for Q2 2023 was $―. For the 2023 fiscal year, SRNE's free cash flow was decreased by $-25.69M and operating cash flow was $-55.66M. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 22Dec 21Dec 20Dec 19Dec 18
Operating Cash Flow
$ -234.63M$ -293.86M$ -281.82M$ -159.54M$ -173.00M$ -111.77M
Investing Cash Flow
$ -11.58M$ -28.52M$ 79.85M$ -39.92M$ -38.17M$ -21.20M
Financing Cash Flow
$ 246.59M$ 311.72M$ 181.33M$ 174.24M$ 78.89M$ 326.00M
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
$ 197.91M$ 23.63M$ 36.66M$ 56.46M$ 80.77M$ 213.33M
Income Tax Paid Supplemental Data
$ 26.00K$ 29.00K$ 1.20M$ 0.00$ 13.00K$ 6.00K
Interest Paid Supplemental Data
$ 3.17M$ 1.17M$ 1.06M$ 3.42M$ 12.74M$ 1.62M
Issuance Of Capital Stock
$ 71.45M--$ 317.87M$ 47.70M$ 83.61M
Issuance Of Debt
$ 5.02M$ -92.24M$ -35.91M$ 18.59M$ 25.41M$ 284.64M
Repayment Of Debt
$ -80.53M$ -188.31M$ -85.66M$ -205.56M$ -3.07M$ -42.47M
Free Cash Flow
$ -187.41M$ -307.51M$ -281.82M$ -166.06M$ -184.44M$ -122.96M
Domestic Sales
------
Foreign Sales
------
Currency in USD

Sorrento Therapeutics Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis